IMAKREBIN

This brand name is authorized in Estonia, Hong Kong, Croatia, Poland, Romania

Active ingredients

The drug IMAKREBIN contains one active pharmaceutical ingredient (API):

1 Imatinib UNII 8A1O1M485B - IMATINIB MESYLATE

Imatinib is a protein-tyrosine kinase inhibitor which potently inhibits the Bcr-Abl tyrosine kinase at the in vitro, cellular and in vivo levels. Read about Imatinib

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L01EA01	Imatinib	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01E Protein kinase inhibitors → L01EA BCR-ABL tyrosine kinase inhibitors
Discover more medicines within L01EA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1548187, 1548288, 1548682, 1548693, 1548705, 1548716, 1548727, 1548738, 1548749, 1548750, 1548761, 1548772, 1548783, 1548794
Country: HK	Department of Health Drug Office	Identifier(s): 62351, 62352
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-833441349, HR-H-922215032
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100294211, 100294240
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W67616001, W67616002, W67616003, W67616004, W67616005, W67616006, W67616007, W67617001, W67617002, W67617003, W67617004, W67617005, W67617006, W67617007